Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monoamine Contributions to Neurocircuitry in Eating Disorders
NCT02020408Phase 4Completed
- Sponsor
- University of California, San Diego
- Start
- May 2011
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial, sponsored by University of California, San Diego. Primary endpoint: 5-HT Transporter Binding as Measured During the PET Scan at 90 minutes. Started May 2011; status: completed.
Beyond the preview
Go deeper on NCT02020408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02020408.